CRT 2023

Early Feasibility Study and Breakthrough Devices Programs: FDA Update

Speaker(s)

• 

  Andrew Farb, MD

  Chief Medical Officer, Division of Cardiovascular Devices
  U.S. Food and Drug Administration
  Silver Spring, Maryland, United States

  No relationships to disclose